Stephens Starts Ideaya Biosciences (IDYA) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Price: $33.63 +2.28%
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 17
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 17
Join SI Premium – FREE
Stephens analyst Sudan Loganathan initiates coverage on Ideaya Biosciences (NASDAQ: IDYA) with a Overweight rating and a price target of $51.00.
For an analyst ratings summary and ratings history on Ideaya Biosciences click here. For more ratings news on Ideaya Biosciences click here.
Shares of Ideaya Biosciences closed at $26.64 yesterday.
You May Also Be Interested In
- Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens - Doctor Feedback for Darovasertib Positive
- Truist Securities Starts Evergy (EVRG) at Buy
- JPMorgan Starts WinWay Technology Co (6515:TT) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
